Stocks and Investing
Stocks and Investing
Mon, September 25, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 22, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tim Anderson Upgraded (AZN) to Buy on, Sep 22nd, 2017
Tim Anderson of Bernstein, Upgraded "AstraZeneca PLC" (AZN) to Buy on, Sep 22nd, 2017.
Tim has made no other calls on AZN in the last 4 months.
There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, 1 agrees with Tim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Seamus Fernandez of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, July 27th, 2017
This is the rating of the analyst that currently disagrees with Tim
- Alex Arfaei of "BMO Capital" Initiated at Buy and Held Target at $38 on, Thursday, September 7th, 2017